• Topic Hubs
    • AI drug discovery: News, analysis and interviews
    • Antibody-drug conjugates: The next wave of targeted cancer drugs
    • Biopharma M&A and dealmaking: Who’s buying and why
    • Biopharma people moves: CEO changes, executive hires, board positions
    • Biotech IPOs: Tracking the market for new public offerings
    • Biotech venture funding: Who’s raising and where the money is going
    • Cell and gene therapy manufacturing: Scaling the next frontier
    • China biotech: Licensing deals and the Biosecure Act
    • CRISPR and gene editing: The push for in vivo therapies
    • Drug pricing and the IRA: Tracking the government's negotiation power
    • FDA policy and drug approvals: What’s changing for biopharma
    • GLP-1 drugs: The obesity pipeline race and what's next
  • Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Signal
  • More
    • Work at Endpoints
    • Biopharma Jobs
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN
    {@!--LOGTO_LOGIN_BUTTON--!@}

Health tech fund­ing ris­es to $7.4B in the first half of 2026

4 minutes ago
Health Tech

Bio­phar­ma's 'ex­tra­or­di­nary year' for M&A sets tone as earn­ings cy­cle be­gins

1 hour ago
Deals
Pharma

Tris Phar­ma's CRL for nar­colep­sy drug; Agenus aban­dons Phase 3 CRC tri­al

1 hour ago
News Briefing

Deals, deals, deals; Bio­haven takes on Eli Lil­ly; and more

2 days ago
Weekly

Ap­n­imed files for IPO as FDA re­views its sleep ap­nea drug

2 days ago
Deals
IPOs

FDA re­turns to re­leas­ing phar­ma re­jec­tion let­ters with 14 new CRLs

2 days ago
FDA+

FDA re­jects Hen­grui-El­e­var liv­er can­cer drug com­bo for third time

2 days ago
China
FDA+

CDER adds 100+ new em­ploy­ees in a quar­ter for first time since late 2024

2 days ago
People
FDA+

'We're para­noid.' As Chi­na biotech com­pe­ti­tion heats up, Amer­i­can drug­mak­ers get more se­cre­tive

3 days ago
R&D
China

Ger­man law­mak­ers pass cost-sav­ing bill that drug­mak­ers say will dri­ve them out

3 days ago
Pharma
Law

Han­soh meets Phase 3 SCLC goal; FDA ap­proves Sanofi on-body in­jec­tor

3 days ago
News Briefing

The da­ta that led an AI biotech to pick up Novo's Parkin­son's stem cell ther­a­py

3 days ago
R&D
Cell/Gene Tx

Pfiz­er ap­points obe­si­ty dis­cov­ery head; AI start­up Xaira makes lead­er­ship ad­just­ments

3 days ago
Peer Review

ARPA-H book­marks $160M for cus­tom gene edit­ing treat­ments. Is it enough?

3 days ago
R&D
Cell/Gene Tx

HHS ad­vances plan to pay out Covid-19 vac­cine in­jury claims

3 days ago
Pharma
FDA+

Roche ends work on tomin­ersen af­ter decade of tri­als, as well as ear­ly-stage Hunt­ing­ton’s as­set

3 days ago
R&D

UK price watch­dog rec­om­mends against Am­gen's Lumakras in lung can­cer

3 days ago
Pharma
FDA+

FDA crit­i­cizes Lund­beck for web­pages pro­mot­ing mi­graine treat­ment Vyep­ti

3 days ago
FDA+

FDA qui­et­ly stops re­leas­ing CRLs

4 days ago
FDA+
Manufacturing

The biggest health tech sto­ries of 2026 — so far

4 days ago
Health Tech

Ipsen suc­ceeds in mi­graine tri­als; Tar­sus buys iRenix for $75M up­front

4 days ago
News Briefing

Lil­ly was al­ready phar­ma's biggest com­pa­ny. Now it's do­ing deals to match

4 days ago
Deals
Pharma

Catal­ent to di­vest UK site; Rot­ten­dorf, Evonik an­nounce man­u­fac­tur­ing builds

4 days ago
Manufacturing

GSK walks away from Alec­tor pact as im­muno-neu­rol­o­gy bet fiz­zles

4 days ago
Deals
Pharma
1234 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2026

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times